back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2016-12-22 Tx date 2016-08-02 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Whitaker, Anne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-2,500 vol |
42,935 | |
| Filed 2016-12-22 Tx date 2016-08-02 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Whitaker, Anne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$58,850
+2,500 vol $23.54 each |
10,000 | |
| Filed 2016-12-22 Tx date 2016-12-05 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Whitaker, Anne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-108,216
-6,012 vol $18.00 each |
15,799 | |
| Filed 2016-12-22 Tx date 2016-12-05 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Whitaker, Anne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-117,090
-6,505 vol $18.00 each |
||
| Filed 2016-12-22 Tx date 2016-08-02 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Whitaker, Anne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-19,632.36
-834 vol $23.54 each |
9,166 | |
| Filed 2016-12-12 Tx date 2016-12-05 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Whitaker, Anne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-117,090
-6,505 vol $18.00 each |
13,640 | |
| Filed 2016-12-12 Tx date 2016-12-05 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Whitaker, Anne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$227,610
+12,645 vol $18.00 each |
20,145 | |
| Filed 2016-12-12 Tx date 2016-12-05 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Whitaker, Anne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-12,645 vol |
32,790 | |
| Filed 2016-05-16 Tx date 2016-05-12 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Whitaker, Anne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$945,719
+37,935 vol $24.93 each |
45,435 | |
| Filed 2015-07-22 Tx date 2015-07-20 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Whitaker, Anne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$1,799,100
+7,500 vol $239.88 each |
7,500 | |
| Filed 2015-07-22 Tx date 2015-05-13 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Whitaker, Anne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-24 Tx date 2015-05-13 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Whitaker, Anne
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-24 Tx date 2015-05-13 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Whitaker, Anne
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
$8,242,951
+37,485 vol $219.90 each |
37,485 |